Imed Infinity Medical-Limited Partnership (IMED.TA)
ILA 99.8
(0.0%)
ILA 99.8
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Operating Cash Flow | -609 Thousand | -1.29 Million | -903 Thousand | 236 Thousand |
| Net Income | -1.77 Million | -1 Million | -766 Thousand | -136 Thousand |
| Depreciation & Amortization | - | - | - | - |
| Deferred income taxes | - | - | - | - |
| Stock-based compensation | - | - | 36 Thousand | 4000.00 |
| Change in working capital | 216 Thousand | -54 Thousand | -163 Thousand | -72 Thousand |
| Other non-cash items | 945 Thousand | -236 Thousand | -10 Thousand | 440 Thousand |
| Investing Cash Flow | -50 Thousand | -750 Thousand | -2.8 Million | -15.01 Million |
| Investments in PPE | - | - | - | - |
| Acquisitions | - | - | - | - |
| Investment purchases | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | -50 Thousand | -750 Thousand | -2.8 Million | -15.01 Million |
| Financing Cash Flow | - | - | - | 46.59 Million |
| Debt repayment | - | - | - | - |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | - | - | - | - |
| Other Financing Activities | - | - | - | 46.59 Million |
| Accounts receivables | -9000.00 | 8000.00 | -18 Thousand | - |
| Accounts payables | - | - | - | - |
| Inventory | - | - | - | - |
| Other working capital | 225 Thousand | -62 Thousand | -145 Thousand | -72 Thousand |
| Cash at beginning of period | 2.2 Million | 4.25 Million | 24.68 Million | - |
| Cash at end of period | 1.54 Million | 2.2 Million | 4.25 Million | 102.27 Million |
| Capital Expenditure | - | - | - | - |
| Effect of forex changes on cash | - | - | - | 70.45 Million |
| Net cash flow / Change in cash | -659 Thousand | -2.04 Million | -20.43 Million | 102.27 Million |
| Free Cash Flow | -609 Thousand | -1.29 Million | -903 Thousand | 236 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -227.5 Thousand | -227.5 Thousand | -1.77 Million | -377 Thousand | -377 Thousand | -508 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -6000.00 | -6000.00 | 216 Thousand | 122 Thousand | 122 Thousand | -14 Thousand |
| Other non-cash items | 55 Thousand | 55 Thousand | 945 Thousand | 209 Thousand | 209 Thousand | 263.5 Thousand |
| Investing Cash Flow | -12 Thousand | -12 Thousand | -50 Thousand | -25 Thousand | -25 Thousand | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -12 Thousand | -12 Thousand | -50 Thousand | -25 Thousand | -25 Thousand | - |
| Financing Cash Flow | - | - | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | -6000.00 | -6000.00 | -9000.00 | -4500.00 | -4500.00 | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | 225 Thousand | 126.5 Thousand | 126.5 Thousand | -14 Thousand |
| Cash at beginning of period | - | - | 2.2 Million | - | - | -699.6 Thousand |
| Cash at end of period | -190.5 Thousand | -190.5 Thousand | 1.54 Million | -71 Thousand | -71 Thousand | -958.1 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -190.5 Thousand | -190.5 Thousand | -659 Thousand | -71 Thousand | -71 Thousand | -258.5 Thousand |
| Free Cash Flow | -178.5 Thousand | -178.5 Thousand | -609 Thousand | -46 Thousand | -46 Thousand | -258.5 Thousand |
294870
SQX
300305
SVSO
8454
BTU